Applicant, as named in the Orange Book

Janssen R And D

Johnson & Johnson · NYSE: JNJ

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis

None.

Intelence · Generic approved · ANDA 219152, BionpharmaApproved 2 Oct 2025Detected 25 Oct 2026

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Intelence NDA 022187 · 3 strengths etravirine	etravirine	open now no listed protection	no listed protection